Olodaterol, a new once-daily LABA, proven effective for COPD
www.pulmccm.org
Olodaterol Olodaterol, a new once-daily inhaled long-acting beta agonist, improved lung function and exercise capacity in chronic obstructive pulmonary disease (COPD) in two randomized trials (n=199) presented by Gregory Feldman et al at the Chest 2013 meeting in Chicago.
Olodaterol, a new once-daily LABA, proven effective for COPD
Olodaterol, a new once-daily LABA, proven…
Olodaterol, a new once-daily LABA, proven effective for COPD
Olodaterol Olodaterol, a new once-daily inhaled long-acting beta agonist, improved lung function and exercise capacity in chronic obstructive pulmonary disease (COPD) in two randomized trials (n=199) presented by Gregory Feldman et al at the Chest 2013 meeting in Chicago.